<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0036">
 <label>36</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>McClue</surname>
    <given-names>SJ</given-names>
   </string-name>, 
   <string-name>
    <surname>Blake</surname>
    <given-names>D</given-names>
   </string-name>, 
   <string-name>
    <surname>Clarke</surname>
    <given-names>R</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>
   <italic>In vitro</italic> and 
   <italic>in vivo</italic> antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine)
  </article-title>. 
  <source>Int J Cancer</source>
  <year>2002</year>;
  <volume>102</volume>:
  <fpage>463</fpage>–
  <lpage>8</lpage>.
  <pub-id pub-id-type="pmid">12432547</pub-id>
 </mixed-citation>
</ref>
